Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10
- PMID: 21087085
- DOI: 10.1515/BC.2010.144
Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10
Abstract
Aldo-keto reductase family 1 member B10 (AKR1B10), over-expressed in multiple human cancers, might be implicated in cancer development and progression via detoxifying cytotoxic carbonyls and regulating fatty acid synthesis. In the present study, we investigated the ortholog of AKR1B10 in mice, an ideal modeling organism greatly contributing to human disease investigations. In the mouse, there are three aldo-keto reductase family 1 subfamily B (AKR1B) members, i.e., AKR1B3, AKR1B7, and AKR1B8. Among them, AKR1B8 has the highest similarity to human AKR1B10 in terms of amino acid sequence, computer-modeled structures, substrate spectra and specificity, and tissue distribution. More importantly, similar to human AKR1B10, mouse AKR1B8 associates with murine acetyl-CoA carboxylase-α and mediates fatty acid synthesis in colon cancer cells. Taken together, our data suggest that murine AKR1B8 is the ortholog of human AKR1B10.
Similar articles
-
Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells.J Biol Chem. 2008 Feb 8;283(6):3418-3423. doi: 10.1074/jbc.M707650200. Epub 2007 Dec 1. J Biol Chem. 2008. PMID: 18056116
-
Human and rodent aldo-keto reductases from the AKR1B subfamily and their specificity with retinaldehyde.Chem Biol Interact. 2011 May 30;191(1-3):199-205. doi: 10.1016/j.cbi.2011.02.007. Epub 2011 Feb 15. Chem Biol Interact. 2011. PMID: 21329680 Free PMC article.
-
Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway.Int J Clin Exp Pathol. 2014 Jun 15;7(7):3791-9. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25120755 Free PMC article.
-
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.Recent Pat Anticancer Drug Discov. 2016;11(2):184-96. doi: 10.2174/1574892811888160304113346. Recent Pat Anticancer Drug Discov. 2016. PMID: 26844556 Free PMC article. Review.
-
Aldo-keto reductase family 1 member B1 inhibitors: old drugs with new perspectives.Recent Pat Anticancer Drug Discov. 2009 Nov;4(3):246-53. doi: 10.2174/157489209789206931. Recent Pat Anticancer Drug Discov. 2009. PMID: 19522700 Review.
Cited by
-
Chicory: Understanding the Effects and Effectors of This Functional Food.Nutrients. 2022 Feb 23;14(5):957. doi: 10.3390/nu14050957. Nutrients. 2022. PMID: 35267932 Free PMC article.
-
Perspective on the Structural Basis for Human Aldo-Keto Reductase 1B10 Inhibition.Metabolites. 2021 Dec 13;11(12):865. doi: 10.3390/metabo11120865. Metabolites. 2021. PMID: 34940623 Free PMC article. Review.
-
Plasma Aldo-Keto Reductase Family 1 Member B10 as a Biomarker Performs Well in the Diagnosis of Nonalcoholic Steatohepatitis and Fibrosis.Int J Mol Sci. 2022 May 1;23(9):5035. doi: 10.3390/ijms23095035. Int J Mol Sci. 2022. PMID: 35563425 Free PMC article.
-
Biological role of aldo-keto reductases in retinoic Acid biosynthesis and signaling.Front Pharmacol. 2012 Apr 17;3:58. doi: 10.3389/fphar.2012.00058. eCollection 2012. Front Pharmacol. 2012. PMID: 22529810 Free PMC article.
-
Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls.Chem Biol Interact. 2015 Jun 5;234:261-73. doi: 10.1016/j.cbi.2014.12.028. Epub 2015 Jan 2. Chem Biol Interact. 2015. PMID: 25559856 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources